Trial site
Florida Retina Consultants
Lakeland, Florida 33805, United StatesNot linked to an institution yet
- 12running trials
- 2closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Phase
- Phase 38 trials
- Phase 24 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting8 trials
- Recruiting4 trials
- Completed2 trials
- Lead sponsor
- Jaeb Center for Health Research3 trials
- 4D Molecular Therapeutics2 trials
- Boehringer Ingelheim2 trials
- Regeneron Pharmaceuticals2 trials
- Bayer1 trial
- and 4 more
Running trials
Recruiting
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
NCT07553429· Phase 1/2· Boehringer Ingelheim· Source
Contact: Boehringer Ingelheim
Recruiting
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
NCT07440225· Phase 2/3· EyeBiotech Ltd.· Source
Contact: Study Coordinator
Recruiting
Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR
NCT06790784· Phase 3· Jaeb Center for Health Research· Source
Contact: Scott M. Friedman, MD
Recruiting
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
NCT07064759· Phase 3· 4D Molecular Therapeutics· Source
Contact: 4DMT Patient Advocacy
Active, not recruiting
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
NCT06864988· Phase 3· 4D Molecular Therapeutics· Source
Active, not recruiting
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration
NCT06495918· Phase 3· Ocular Therapeutix, Inc.· Source
Recruiting
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
NCT06541704· Phase 3· Regeneron Pharmaceuticals· Source
Contact: Clinical Trials Administrator
Active, not recruiting
A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56
NCT06668064· Phase 3· EyePoint Pharmaceuticals, Inc.· Source
Active, not recruiting
A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)
NCT06491914· Phase 3· Regeneron Pharmaceuticals· Source
Recruiting
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
NCT06321302· Phase 2· Boehringer Ingelheim· Source
Contact: Boehringer Ingelheim
Active, not recruiting
Evaluation of Tonabersat for DME
NCT05727891· Phase 2· Jaeb Center for Health Research· Source
Active, not recruiting
Fenofibrate for Prevention of DR Worsening
NCT04661358· Phase 3· Jaeb Center for Health Research· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error